Aims/Introduction: The aim of the present study was to determine the predictors of deterioration of glucose tolerance in individuals with normal glucose tolerance (NGT) and abdominal obesity, and whether a lifestyle intervention to reduce visceral fat is effective in these individuals. Materials and Methods: The study subjects were 251 individuals who had abdominal obesity with certain risk factors (hypertension, high fasting plasma glucose (FPG), elevated hemoglobin A 1c (HbA 1c ), dyslipidemia and hyperuricemia) and underwent oral glucose tolerance test (OGTT) in 2004 and 2005. Results: Using the area under the receiver operating characteristic curve, we found that PG at 0 min, 60 min, and area under the curve (AUC) of glucose from 0 to 120 min (AUC [glucose 0-120 ]) in OGTT were significant predictors of deterioration of glucose tolerance, with optimal cut-off values of 95 mg/dL, 158 mg/dL and 271 mg h/dL, respectively. Although the rate of deterioration of glucose tolerance didn't decrease with reductions in visceral fat area (VFA) over the 1-year period in subjects with NGT, the rate tended to decrease with reductions in VFA in high-risk NGT subjects (PG at 0 min > 95 or at 60 min > 158, or AUC [glucose 0-120 ] > 271). Conclusions: These results suggest that reduction of visceral fat over 1 year might not be beneficial in all subjects with NGT, but is beneficial in high-risk NGT. We propose that individuals with values of the aforementioned predictors higher than the cut-off levels, even those with NGT, should receive a lifestyle intervention program aimed at reducing visceral fat to prevent deterioration of glucose tolerance. (J Diabetes Invest,
INTRODUCTION
Visceral fat accumulation is associated with the development of metabolic disorders, including glucose intolerance. However, not all subjects with abdominal obesity develop hyperglycemia. Individuals with pre-diabetic conditions, including impaired glucose tolerance (IGT), are already at high risk of the development of atherosclerosis [1] [2] [3] , as well as microvascular complications 4 . Thus, to prevent these complications, it is important to identify individuals with normal glucose tolerance (NGT), especially those with abdominal obesity, who could progress to glucose intolerance and design interventions to delay such deterioration. The aim of the present study was to determine predictors that can identify subjects with abdominal obesity who might develop glucose intolerance and to investigate whether a lifestyle intervention aimed at reducing visceral fat is effective in these individuals.
MATERIALS AND METHODS

Subjects
The study group comprised 3827 Japanese subjects (2854 men and 973 women) who were employees of the Amagasaki City Office, Hyogo, Japan (an urban area) and had completed the government-funded annual health checkup in 2004. Among the tests carried out during the annual examination, oral glucose tolerance test (OGTT) was carried out in 783 subjects who had abdominal obesity and one or more risk factor(s). Abdominal obesity represented a waist circumference ‡85 cm in men and 90 cm in women fasting plasma glucose (FPG) level of ‡110 mg/dL and/or Hemoglobin A 1c (HbA 1c ) level of ‡5.5%; (iii) dyslipidemia: a serum triglyceride level of ‡150 mg/dL and/or a serum highdensity lipoprotein (HDL) cholesterol level of <40 mg/dL, and/ or a serum low-density lipoprotein (LDL) cholesterol level of ‡140 mg/dL; and (iv) hyperuricemia: a serum uric acid level of ‡7.0 mg/dL. These subjects were provided with health guidance to improve their lifestyle and to reduce visceral fat 6 . In 2004, there were 373 subjects who were identified as NGT and, finally, 251 subjects (240 men and 11 women) who could be followed by OGTT in the next year were included in the present analysis. In addition, we also analyzed 107 subjects (96 men and 11 women) who were identified to have impaired fasting glucose (IFG) and/or IGT in 2004 and could be re-examined in 2005.
Anthropometry
Anthropometric variables (height, weight and waist circumference [WC]) were measured in standing position. Body mass index (BMI) was calculated as weight (kg) divided by the square of height in meters (m 2 ). WC at the umbilical level was measured in cm with a non-stretchable tape in the late exhalation phase in the standing position 7 . Blood pressure was measured in the sitting position.
Laboratory Tests
Plasma glucose was determined by the glucose oxidase method. HbA 1c was determined by high-performance liquid chromatography. Serum uric acid (UA), total cholesterol and triglyceride concentrations were determined by enzymatic methods. LDL and HDL cholesterol were also measured by an enzymatic method after heparin and calcium precipitation.
Detailed Examination
Visceral fat area (VFA) was determined by the bioelectrical impedance analysis (BIA) method, as reported previously 8 . OGTT was carried out in subjects with abdominal obesity with one or more risk factor(s). In this test, plasma glucose and serum insulin concentrations were determined at 0, 30, 60 and 120 min after 75 g glucose ingestion by the glucose oxidase method and doubleantibody radioimmunoassay, respectively. Insulinogenic index (I.I.) was calculated by dividing the increment in serum insulin by the increment in plasma glucose from 0 to 30 min of the OGTT. The area under the glucose and insulin curves (AUC [glucose 0-120 ], AUC [insulin 0-120 ]) were calculated by the trapezoid rule. The diagnoses of diabetes, IFG, IGT and NGT were based on the criteria of the American Diabetes Association 9 . Adiponectin (APN) was measured using the latex particle-enhanced turbidimetric 
Statistical Analysis
Comparison of variables between groups was carried out using an unpaired Student's t-test. Comparisons of variables between 2004 and 2005 in the NGT group and in the IFG and/or IGT group were carried out using a paired Student's t-test. APN, I.I. and homeostasis model of insulin resistance (HOMA-IR) variables were log transformed and analyzed. The area under the receiver operating characteristic (ROC) curve was used to evaluate the predictive power of various parameters. All analyses except ROC analysis were carried out using StatView, version 5 (SAS Institute, Cary, NC, USA). ROC analysis was carried out using Dr. SPSS II, standard version (SPSS, Chicago, IL, USA). Data are expressed as mean ± SD. A P-value of <0.05 was considered statistically significant.
RESULTS
The clinical characteristics of the subjects with NGT and IFG and/or IGT at baseline and in the next year are presented in Table 1 Table 2 compares the 2004 clinical variables of subjects of the NGT group who showed deterioration in glucose tolerance in 2005 (worsening group) and of those who retained NGT (retaining group). WC, VFA, sBP, dBP, HbA 1c , PG at 0, 30, 60 and 120 min, and AUC (glucose 0-120 ) in OGTT were significantly higher and log (I.I.) was significantly lower in the worsening group than in the retaining group. However, BMI, TC, TG, HDLC, LDLC, UA, log (APN), IRI at 0, 30, 60 and 120 min, AUC (insulin 0-120 ) in OGTT, and log (HOMA-IR) were not significantly different between the two groups. The area under the ROC curve was used to evaluate the predictive power of the parameters that were significantly different between the two groups. The areas under the ROC curve of all these parameters were significantly higher than 0.5 (Table 3) . Among them, the areas under the ROC curve of PG at 0 min, 60 min and AUC (glucose 0-120 ) in OGTT were higher than approximately 0.7, showing that these parameters are significant predictors of deterioration of glucose tolerance. ROC curves of these predictors are presented in Figure 1 . Next, we determined the optimal cut-off points for these parameters to predict deterioration in glucose tolerance according to the Youden index. The optimal cut-off points for PG at 0 min, 60 min and AUC (glucose 0-120 ) in OGTT were 95 mg/dL, 158 mg/dL and 271 mg h/dL, respectively. The sensitivity and specificity of these cut-off points were 0.67 and 0.64 for PG at 0 min, 0.67 and 0.75 for PG at 60 min, and 0.78 and 0.71 for AUC (glucose 0-120 ), respectively. 2005 (worsening group 2), and those who retained IFG and/or IGT or improved to NGT (retaining or improving group 2) in 2005. Age, HbA 1c , PG at 0, 30 min, AUC (glucose 0-120 ) in OGTT were significantly higher in the worsening group 2 than in the retaining or improving group 2. The areas under the ROC curve of all these parameters were significantly higher than 0.5 (Table 3) . Among them, the areas under the ROC curves of PG at 0, 30 min in OGTT were higher than 0.7, and their optimal cut-off levels were 111 and 182 mg/dL, respectively. The sensitivity and specificity of these cut-off points were 0.73 and 0.72 for PG at 0 min, and 0.87 and 0.49 for PG at 30 min, respectively. Finally, we investigated whether changes in VFA over the 1-year period were associated with changes in glucose tolerance in subjects with NGT. For this purpose, we divided the subjects into three groups according to the mean ± 1 SD of changes in VFA and calculated the incidence rates of worsening of glucose tolerance. As shown in Figure 2 , the rate of worsening of glucose tolerance in NGT subjects did not decrease with decreases in VFA over 1 year. In contrast, the rate of development of DM in IFG and/or IGT subjects tended to decrease with decreases in VFA over 1 year (Figure 2 ), although not significantly (Table 5) . A similar analysis was carried out for data of subjects of the NGT with PG at 0 min of >95 mg/dL or PG at 60 min of >158 mg/dL or AUC (glucose 0-120 ) of >271 mg h/dL, who were at high risk of deterioration of glucose tolerance according to the results obtained in the present study. The rate of worsening of glucose tolerance tended to decrease with decrease in VFA in these subjects (Figure 3) , although not significantly (Table 5) . Because all subjects of the worsening group were male, we focused on the data in male subjects and re-calculated the rate of worsening of glucose tolerance, and we obtained a similar results (data not shown).
DISCUSSION
In the present study, we found that WC, VFA, sBP, dBP, HbA 1c , PG at 0, 30, 60 and 120 min, AUC (glucose 0-120 ) of OGTT and log (I.I.) can predict deterioration of glucose tolerance over 1 year in NGT subjects with abdominal obesity, and that the power of PG at 0, 60 min and AUC (glucose 0-120 ) was relatively the strongest among these variables. Furthermore, we calculated the optimal cut-off values of these parameters: 95 mg/dL for PG at 0 min, 158 mg/dL for PG at 60 min, and 271 mg h/dL for AUC (glucose 0-120 ). It has already been reported that the PG at 60 min during OGTT is a strong predictor of future risk of type 2 diabetes with a cut-off value of 155 mg/dL 11 . Although the report was based on data about the risk of type 2 diabetes during a 7-8-year follow-up period, the cut-off value of PG at 60 min described in the aforementioned study was almost similar to that computed in the present study. In addition, the same study also showed that NGT subjects with PG at 60 min of >155 mg/dL, who also fulfilled the criteria for the metabolic syndrome, were at greater risk of developing diabetes. Together, with the aforementioned study, the present results suggest that NGT subjects with abdominal obesity with PG at 60 min of >155-158 mg/dL are at high risk of deterioration of glucose tolerance over both a short and long period.
The present results also showed that the rate of worsening of glucose tolerance in NGT subjects did not decrease with decreases in VFA over the 1-year period, suggesting that reducing visceral fat over 1 year had no beneficial effect on glucose tolerance in NGT. In contrast, the rate of developing DM in IFG and/or IGT subjects tended to decrease with decreases in VFA over a 1-year period. These results are in agreement with those of Schäfer et al.
12
, who showed that moderate weight loss under a lifestyle intervention program with reduction in visceral fat improved glucose tolerance in individuals with IGT, but not with NGT. Their follow-up period was 7-11 months, and was as short as ours. It is possible that the beneficial effects of reduction of visceral fat in NGT might not become apparent over a short period of time and that such intervention in NGT might prevent future deterioration of glucose tolerance over a longer period of time. In fact, the F-IRI decreased significantly, similar to VFA, over the 1-year period, even in NGT subjects in the present study (Table 1) , which should lead to conservation of future insulin secretion capacity. We also addressed the question of whether reductions in visceral fat have beneficial effects in NGT subjects with PG at 0 min of >95, PG at 60 min of >158, or AUC (glucose 0-120 ) of >271, who are at high risk of worsening of glucose tolerance based on the results of the present study. The results showed that these subjects benefit from such reduction, similar to persons with IFG and/or IGT. We propose that the individuals with these parameters over the cut-off values should receive a lifestyle intervention program aimed at decreasing visceral fat, even in NGT.
The present study has limitations. The number of subjects included in the present analysis was approximately two-thirds of those identified as NGT in 2004, and we could not follow the rest of the subjects by OGTT in 2005. When we compared the . It might be that we analyzed subjects with relatively severe abdominal obesity.
Although we found various factors, including WC, VFA and log (I.I.), were involved in significant predictors of deterioration of glucose tolerance from NGT to IFG/IGT, only HbA 1c , PG at 0 and 30 min, and AUC (glucose 0-120 ) in OGTT were significantly higher in the worsening groups from IFG/IGT to DM. We speculate that WC and VFA dropped out from such factors in IFG/IGT, probably because visceral fat is likely to decrease by intervention in larger WC and VFA individuals, leading to an improvement in glucose tolerance. Thus, we might not be able to predict deterioration of glucose tolerance by only using these parameters in the IFG/IGT group. Regarding log (I.I.), the P-value was 0.0648, suggesting that it might be defined as a significant predictor if evaluated in a larger sample size.
In conclusion, the present study identified certain predictors in NGT subjects with abdominal obesity for deterioration of glucose tolerance over a 1-year period, these include PG at 0 and 60 min, and AUC (glucose 0-120 ) in OGTT. The results also showed that lifestyle intervention that results in reduction of visceral fat does not prevent deterioration of glucose tolerance in NGT, although such a program seems beneficial in subjects with the aforementioned predictors at levels higher than the cut-off points. We propose that individuals with PG at 0 and 60 min, and AUC (glucose 0-120 ) higher than the cut-off values, including NGT, should receive a lifestyle intervention aimed at reducing visceral fat. Further studies of larger population samples and longer follow-up periods are warranted.
